AzTrials
AzTrials

Pulp Disease, DentalNCT07852312

Clinical Outcomes of Root Canal Treatment Using Modern Irrigation Protocols

A study testing GentleWave®, EdgePRO™ and Fotona LightWalker® in people with Pulp Disease, Dental, run by University of Illinois Chicago at 1 site in United States.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Post-operative pain remains a frequent complication after root canal treatments. This clinical trial evaluates the post-operative outcome following endodontic treatments using four irrigation approaches: conventional needle irrigation, GentleWave®, EdgePRO™, and Fotona LightWalker®. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Pulp Disease, Dental
What is being tested?
GentleWave®, EdgePRO™ and Fotona LightWalker®
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
200 participants
Where
1 siteUnited States
Study dates
Sep 2026to Oct 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adults older than 18 years of age who need root canal treatment.

Who cannot join

  • The intake of analgesics within the previous 8h, substance abuse, additional pulpal pathology on the same side, systemic conditions classified as ASA III or higher.
  • Adults unable to consent, minors less than 18 years of age, pregnant women, and prisoners

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Anh M Bui, DMD contact

847-749-6589

abui20@uic.edu

Qian Xie, BDS, MS, PhD contact

xieqian@uic.edu

United States1 site
  • University of Illinois Chicago, College of Dentistry, Department of Endodontics

    Chicago, Illinois, 60612

    Anh M Bui, DMD, 847-749-6589, anhb826@gmail.com

    Qian Xie, BDS, MS, PhD, xieqian@uic.edu

Other trials in United States

About this study

Post-operative pain remains a frequent complication after root canal treatments. This clinical trial evaluates the post-operative outcome following endodontic treatments using four irrigation approaches: conventional needle irrigation, GentleWave®, EdgePRO™, and Fotona LightWalker®. The study will assess patients' post-operative pain and other symptoms following treatment, as well as healing of the tissues around the treated tooth over time.

Read the detailed description

Conventional needle irrigation is the traditional method that uses a syringe and needle to deliver irrigation solutions into the root canal system to flush out tissue and debris in endodontic therapy. GentleWave®, EdgePRO™, and Fotona LightWalker® are advanced endodontic irrigation systems approved by the Federal Drug Administration as medical devices to prepare, clean, and irrigate root canal anatomy during endodontic therapy. The study compares the post-operative outcome between 4 groups: conventional needle irrigation, irrigation with GentleWave®, irrigation with EdgePRO™, and irrigation with Fotona LightWalker® in root canal treatments. Participants will be asked to report the level of post-operative pain by telephone at approximately 6, 24, 48, and 72 hours after treatment. Each pain assessment will take less than one minute. Participants will also be asked to return to the clinic for follow-up examinations at approximately 6 and 12 months after treatment. Each follow-up visit will take approximately 30 minutes.

Being tested
GentleWave®, EdgePRO™, Fotona LightWalker®, Conventional Needle Irrigation
Medical subject headings
Dental Pulp Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • GentleWave®Device

    An advanced endodontic irrigation system that utilizes a vortex of fluids and acoustic energy that cleans the deepest, most complex portions of the root canal system.

    Regulatory approval status: FDA cleared

    Post-operative pain information will be collected via phone interview.

    Complications and adverse effects are the same as with other systems of similar design and traditional root canal therapy, and may include sensitivity, inflammation, and pain.

  • EdgePRO™Device

    An advanced endodontic irrigation system that delivers Laser Light Sound Energy at a specific wavelength and frequency to the irrigants in the canal to form Cavitation Waves throughout the root canal system. This allows optimal cleaning, debridement, and disinfection of the root canal system.

    Regulatory approval status: FDA cleared

    Post-operative pain information will be collected via phone interview.

    Complications and adverse effects are the same as with other systems of similar design and traditional root canal therapy, and may include sensitivity, inflammation, and pain.

  • Fotona LightWalker®Device

    An advanced endodontic irrigation system that combines Er:YAG and Nd:YAG wavelengths to optimize pulse control, intuitive interface, and minimally invasive approach to enhance patient outcomes, improve efficiency, and expand clinical capabilities.

    Regulatory approval status: FDA cleared

    Post-operative pain information will be collected via phone interview.

    Complications and adverse effects are the same as with other systems of similar design and traditional root canal therapy, and may include sensitivity, inflammation, and pain.

  • Conventional Needle IrrigationDevice

    Conventional needle irrigation is the traditional method that uses a syringe and needle to deliver irrigation solutions into the root canal system to flush out tissue and debris in endodontic therapy.

    Post-operative pain information will be collected via phone interview.

    Complications and adverse effects are the same as with other systems of similar design and traditional root canal therapy, and may include sensitivity, inflammation, and pain.

Study groups in NCT07852312
Study groupRoleWhat they receive
Conventional needle irrigationSham comparatorConventional needle irrigation is the traditional method that uses a syringe and needle to deliver irrigation solutions into the root canal system to flush out tissue and debris in endodontic therapy.
Receives: Device: Conventional Needle Irrigation
Irrigation with GentleWave®Active comparatorAn advanced endodontic irrigation system that utilizes a vortex of fluids and acoustic energy that cleans the deepest, most complex portions of the root canal system.
Receives: Device: GentleWave®
Irrigation with EdgePRO™Active comparatorAn advanced endodontic irrigation system that delivers Laser Light Sound Energy at a specific wavelength and frequency to the irrigants in the canal to form Cavitation Waves throughout the root canal system. This allows optimal cleaning, debridement, and disinfection of the root canal system.
Receives: Device: EdgePRO™
Irrigation with Fotona LightWalker®Active comparatorAn advanced endodontic irrigation system that combines Er:YAG and Nd:YAG wavelengths to optimize pulse control, intuitive interface, and minimally invasive approach to enhance patient outcomes, improve efficiency, and expand clinical capabilities.
Receives: Device: Fotona LightWalker®

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Post-operative pain intensity as assessed by the Numeric Rating Scale (NRS, 0-10)

    Pain intensity self-reported on an 11-point Numeric Rating Scale where 0 = no pain and 10 = worst possible pain. The metric is the mean NRS score per group, reported separately at each time point. Higher scores indicate worse pain.

    Measured: 6, 24, 48, and 72 hours post-treatment

  2. Number of teeth with radiographic periapical healing as assessed by the Periapical Index (PAI)

    Periapical status scored on the 5-point PAI (1 = normal periapical structures; 2 = small bone-structure changes; 3 = bone-structure changes with mineral loss; 4 = well-defined apical radiolucency; 5 = severe periodontitis with exacerbating features) on periapical radiographs by two calibrated, blinded, independent assessors, with a third assessor arbitrating disagreements. For multirooted teeth the highest root score is recorded. Based on the change in PAI between baseline and follow-up, each tooth is classified into one of three categories:

    1. Healing (complete healing): final PAI ≤ 2 with no clinical signs or symptoms (complete radiographic resolution).
    2. Incomplete healing: final PAI reduced compared with baseline but still > 2, with no clinical signs or symptoms (lesion reduced in size but not fully resolved).
    3. Unhealed: PAI unchanged or increased, and/or presence of clinical signs/symptoms (pain, swelling, sinus tract).

    Reported as the proportion (number/total) of teeth.

    Measured: 6- and 12-months post-treatment

  3. Number of teeth meeting clinical success criteria (absence of pain, swelling, sinus tract, and normal function)

    Clinical success defined as a tooth with no spontaneous or provoked pain, no tenderness to percussion/palpation, no swelling, no sinus tract, and normal function. Reported as the proportion (number/total) of teeth meeting all criteria per group.

    Measured: 6 month and 12 month

Secondary outcomes (1)
  1. Analgesic consumption

    Binary: present/absent

    Measured: At 6, 24, 48, and 72 hours post-treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Oct 2026
  2. Study startSep 2026 (estimated)
  3. Primary completionOct 2028 (estimated)
  4. Study completionOct 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07852312
Sponsor's protocol ID
2026-0972
Status last verified
Aug 2026
First submitted
10 Sep 2026
Last updated
1 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No: Information will be kept confidential at all times. No identifiable data will be collected.

Publications

  • Orstavik D, Kerekes K, Eriksen HM. The periapical index: a scoring system for radiographic assessment of apical periodontitis. Endod Dent Traumatol. 1986 Feb;2(1):20-34. doi: 10.1111/j.1600-9657.1986.tb00119.x. No abstract available.

    PubMed 3457698
  • Hawker GA, Mian S, Kendzerska T, French M. Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP). Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S240-52. doi: 10.1002/acr.20543. No abstract available.

    PubMed 22588748

Questions about this trial

What is this clinical trial studying?

A study testing GentleWave®, EdgePRO™ and Fotona LightWalker® in people with Pulp Disease, Dental, run by University of Illinois Chicago at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 1 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Anh M Bui, DMD (847-749-6589, abui20@uic.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Post-operative pain intensity as assessed by the Numeric Rating Scale (NRS, 0-10) (time frame: 6, 24, 48, and 72 hours post-treatment). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07852312, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in